Nonhormonal treatments for abnormal menopause


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper gives the data available in the literature on abnormal menopause, clinical manifestations of climacteric syndrome, and possible complications of menopausal hormone therapy. It describes experience in using magnesium preparations in complex nonhormonal treatment of climacteric syndrome. Co-administration of phytoestrogens with magnesium organic salts preparations (magneB 6) is most effective.

Full Text

Restricted Access

About the authors

Vladimir Nikolaevich Serov

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: v_serov@oparina4.ru
doctor of medical sciences, professor, academician RAMS, president of RSOG

Uliana Vladimirovna Zimovina

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia

Email: rudi_u@mail.ru
PhD

Dmitry Vladislavovich Blinov

N.I. Pirogov Russian National Research Medical University

Email: nevrologia@mail.ru
PhD

Elena Anatolyevna Sandakova

Perm State Medical Academy

Email: selena11perm@yandex.ru
professor, doctor of medicine, header of the department of obstetrics and gynaecology of advanced doctors' studies faculty

References

  1. Дильман В.М. Большие биологические часы (введение в интегральную медицину). М.: Знание; 1982. 208 с. [Dilman V.M. Large biological clock (an introduction to integrative medicine). M.: Znanie; 1982. 208 p. In Russ.]
  2. Bush T.L., Barrett-Connor E., Cowan L.D., Criqui M.H., Wallace R.B., Suchindran C.M. et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987; 75(6): 1102-9.
  3. Sullivan J.M., VanderZwaag R., Hughes J.P., Maddock V., Kroetz F.W., Ramanathan K.B., Mirvis D.M. Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. Arch. Intern. Med. 1990; 150(12): 2557-62.
  4. Grodstein F., Stampfer M., Goldhaber S., Manson J., Colditz G., Speizer F.E. et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet. 1996; 348(9033): 983-7.
  5. Simon J.A., Hsia J., Cauley J.A., Richards C., Harris F., Fong J., Barrett-Connor E., Hulley S.B. Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation. 2001; 103(5): 638-42.
  6. th International Symposium on Women’s Health and Menopause: Abstract book. April 21-24, Florence Italy; 2004.
  7. Овсянникова Т.В., Макаров И.О., Куликов И.А. Клиническая эффективность негормональных методов терапии у женщин в перименопаузе. Акушерство, гинекология и репродукция. 2013; 7(3): 26-9. [Ovsyannikova T.V., Makarov I.O., Kulikov I.A Clinical efficacy of non-hormonal therapies in menopausal women. Obstetrics, Gynecology and Reproduction/Akusherstvo, ginekologiya i reproduktsiya. 2013; 7(3): 26-9. In Russ.]
  8. Low D.A., Humbing K.A., Coso J. Mechanisms of cutaneous vasodilatation during the postmenopausal hot flash. Menopause. 2011; 18(4): 359-65.
  9. Зимовина У.В. Синдром психовегетативной дизрегуляции у женщины в периоде ранней постменопаузы и возможности негормональной и гормональной его коррекции: дис.. канд. мед. наук. Пермь; 2007. 177 с. [Zimovina U.V. Psychovegetative dysregulated syndrome in women in the early postmenopausal period and the possibility of hormonal and nonhormonal its correction. Diss. Perm; 2007. 177 s. In Russ.]
  10. Raghvendra K., Jackson E.K. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am. J. Physiol. Renal Physiol. 2001; 280: F365-88.
  11. Pare G., Krust A., Karas R.H., Dupont S., Aronovitz M., Chambon P., Mendelsohn M.E. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ. Res. 2002; 90(10): 1087-92.
  12. Воробьев А.В., Зимовина У.В., Квиквиния И.З. Заместительная гормональная терапия и профилактика тромботических осложнений. Акушерство, гинекология и репродукция. 2014; 8(2): 27-33. [Vorobyov A.V., Zimovina U.V., Kvikviniya I.Z. Hormone replacement therapy and prevention of thrombotic complications. Obstetrics, gynecology and reproduction/Akusherstvo, ginekologiya i reproduktsiya. 2014; 8 (2): 27-33. In Russ.]
  13. Макацария А.Д., Бицадзе О.В. Тромбофилии и противотромботическая терапия в акушерской практике. М.; 2003. 904 с. [Makatsaria A.D., Bitsadze O.V. Thrombophilia and antithrombotic therapy in obstetric practice. M. ; 2003. 904 p. In Russ. ]
  14. Громова О.А., Торшин И.Ю., Тетруашвили Н.К., Лиманова О.А., Серов В.Н. Молекулярно-фармакологические механизмы стимуляции гиперкоагуляции препаратами пероральных и трансдермальных эстрогенов. Гинекология. 2014; 2: 22-8. [Gromova O.A., Torshin I.Yu., Tetruashvili N.K., Limanova O.A., Serov V.N. Molecular mechanisms of pharmacological stimulation drugs hypercoagulable oral and transdermal estrogen. Gynecology/ Ginekologiya. 2014; 2: 22-8.]
  15. Lowe G.D. Hormone replacement therapy and cardiovascular disease: increased risks of venous thromboembolism and stroke, and no protection from coronary heart disease. J. Intern. Med. 2004; 256: 361-74.
  16. Sweetland S., Beral V., Balkwill A., Liu B., Benson V.S., Canonico M. et al. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J. Thromb. Haemost. 2012; 10(11): 2277-86.
  17. Кузнецова И.В., Коренная В.В. Эстрогенный дефицит в различные возрастные периоды и методы его негормональной коррекции. М.; 2010. 64 с. [Kuznetsova I.V., Korennaya V.V. Estrogen deficiency at different ages and methods of non-hormonal correction. M.; 2010. 64 p. In Russ.]
  18. Дадак К., Макацария А.Д., Блинов Д.В., Зимовина У.В. Клинические и биохимические аспекты применения препаратов магния в акушерстве, гинекологии и перинатологии. Акушерство, гинекология и репродукция. 2014; 8(2): 69-78. [Dadak K., Makatsaria A.D., Blinov D.V., Zimovina U.V. Clinical and biochemical aspects of the use of magnesium preparations in Obstetrics and Gynecology. Obstetrics, gynecology and reproduction/Akusherstvo, ginekologiya i reproduktsiya. 2014; 8 (2): 69-78. In Russ.]
  19. Макацария А.Д., Бицадзе В.О., Хизроева Д.Х., Джобава Э.М. Распространенность дефицита магния у беременных женщин, наблюдающихся в условиях амбулаторной практики. Вопросы гинекологии, акушерства и перинатологии. 2012; 11: 25-34. [Makatsaria A.D., Bitsadze V.O. Hizroeva D.H., Dzobava E.M. Prevalence of magnesium deficiency in pregnant women who have access to the conditions of outpatient practice. Questions of gynecology, obstetrics and perinatology/Voprosyi ginekologii, akusherstva i perinatologii. 2012; 11: 25-34. In Russ.]
  20. Schimatschek H.F., Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res. 2001; 14 (4): 283-90.
  21. Серов В.Н., Блинов Д.В., Зимовина У.В., Джобава Э.М. Результаты исследования распространенности дефицита магния у беременных. Акушерство и гинекология. 2014; 6: 33-41. [Serov V.N., Blinov D.V., Zimovina U.V., Dzhobava E.M. Results of an investigation of the prevalence of magnesium deficiency in pregnant women. Obstetrics and Gynecology/ Akusherstvo i ginekologiya. 2014; 6: 33-41. In Russ.]
  22. Громова О.А., Лиманова О.А., Торшин И.Ю. Систематический анализ фундаментальных и клинических исследований указывает на необходимость совместного использования эстроген-содержащих препаратов с препаратами пиридоксина и магния. Акушерство, гинекология и репродукция. 2013; 7(3): 35-50. [Gromova O.A., Limanova O.A., Torshin I.Yu. Systematic analysis of basic and clinical research indicates the need for sharing of estrogen-containing preparations with preparations of pyridoxine and magnesium. Obstetrics, Gynecology and Reproduction/Akusherstvo, ginekologiya i reproduktsiya. 2013; 7(3): 35-50. In Russ.]
  23. Groenestege W.M., Hoenderop J.G., van den Heuvel L., Knoers N., Bindels R.J. The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens. J. Am. Soc. Nephrol. 2006; 17(4): 1035-43.
  24. Hameed A., Majeed T., Rauf S., Ashraf M., Jalil M.A., Nasrullah M. et al. Effect of oral and injectable contraceptives on serum calcium, magnesium and phosphorus in women. J. Ayub. Med. Coll. Abbottabad. 2001; 13(3): 24-5.
  25. Blum M., Kitai E., Ariel Y., Schnierer M., Bograd H. Oral contraceptive lowers serum magnesium. Harefuah. 1991; 121(10): 363-4.
  26. Межевитинова Е.А., Прилепская В.Н., Назарова Н.М. Применение магне В6 для профилактики побочных реакций гормональной контрацепции. Российский вестник акушера-гинеколога. 2005; 5: 61-2. [Mezhevitinova E.A., Prilepskaya V.N., Nazarova N.M. Application of Magne B6 for the prevention of adverse effects of hormonal contraception. Russian Bulletin of obstetrician-gynecologist/Rossiyskiy vestnik akushera-ginekologa. 2005; 5: 61-2. In Russ.]
  27. Maier J.A., Malpuech-Brugère C., Zimowska W., Rayssiguier Y., Mazur A. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim. Biophys. Acta. 2004; 1689(1): 13-21.
  28. Zhang A., Cheng T.P., Altura B.T., Altura B.M. Mg2+ and caffeine-induced intracellular Ca2+ release in human vascular endothelial cells. Br. J. Pharmacol. 1993; 109: 291-2.
  29. Dickens B.F., Weglicki W.B., Li Y.S., Mak I.T. Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett. 1992; 311(3): 187-91.
  30. Killilea D., Maier J.A. A connection between magnesium deficiency and aging: new insights from cellular studies. Magnes Res. 2008; 21: 77-82.
  31. Shechter M., Merz C.N., Paul-Labrador M., Meisel S.R., Rude R.K., Molloy M.D. et al. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. Am. J. Cardiol. 1999; 84(2): 152-6.
  32. Altura B.M., Altura B.T. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. Experimental aspects. Magnesium. 1985; 4(5-6): 245-71.
  33. Altura B.M. Magnesium neurohypophyseal hormone interactions in contraction of vascular smooth muscle. Am. J. Physiol. 1975; 228(5): 1615-20.
  34. Van Laecke S., Nagler E. V., Vanholder R. Thrombotic microangiopathy: a role for magnesium? Thromb. Haemost. 2012; 107(3): 399-408. doi: 10.1160/TH11-08-0593.
  35. Сандакова Е.А., Зимовина У.В., Касатова Е.Ю. Способ коррекции психовегетативных расстройств у женщин с климактерическим синдромом. Патент № 2334529, РФ. Заявлено 27.03.2007, опубликовано 27.09.2008. [Sandakova E.A., Zimovina U.V., Kasatova E.Yu. The method of correcting psycho-vegetative disorders in women with climacteric syndrome. Patent number 2334529, Russia. Reported 27.03.2007, published on 27.09.2008. In Russ.]

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies